IQVIA Digital Site Suite

  1. Built For Sites To Benefit All 7/15/2024

    This one-minute video highlights the benefits of One Home for Sites. Join the movement to increase clinical trial capacity, because patients are waiting.

  2. Get Your Tile Into One Home for Sites™ 7/15/2024

    When you "get your tile" into One Home, you're building up the library of systems available to sites for single sign-on and task management across their trials.

  3. IQVIA Launches 'One Home' Clinical Trial Technology Platform – Solves Challenges And Reduces Overload At Sites 6/12/2024

    One Home for Sites™ is a new technology platform that acts as a single sign-on and a single dashboard for the key systems and tasks a clinical research site needs to perform across all of the clinical trials it is conducting.

  4. A Strategic Framework For Positive Site-Sponsor Relationships 5/1/2024

    Through an examination of evolving trial strategies and implementation, we aim to lay the groundwork for a collaborative, mutually beneficial atmosphere, ultimately leading to a sustainable competitive edge.

  5. An Introduction To One Home for Sites™ 4/18/2024

    This on-demand webinar provides a thorough overview of why IQVIA Technologies is building One Home for Sites, how it works, and who should participate.

  6. One Home for Sites™ Partnership Program Guide 4/7/2024

    Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.

  7. Study Start-Up Challenges: Hard Realities, Effective Strategies 3/13/2024

    Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?

  8. Introducing One Home for Sites™ 2/8/2024

    One Home for Sites is a vendor-agnostic, sponsor-agnostic, aggregation platform that provides single sign-on and more. Become part of the only industry-wide solution to site tech overload.

  9. Accelerating Site Activation: Examples From Novartis And IQVIA 1/12/2024

    As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.

  10. Q&A With Novartis And IQVIA Study Start-Up Leaders 12/6/2023

    The industry is measuring longer cycle times between protocol approval and site activation. Experts from Novartis and IQVIA share creative solutions to combat this trend and accelerate trial timelines.